Growth and Tumorigenesis in IGF2 Transgenic Mice

Agency: National Institute of Health (NIH)
Institute: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type: Research Project (R01)
Project #: 5R01DK048936-03
Application #: 2149459
Study Section: Diabetes, Endocrinology and Metabolic Diseases B Subcommittee (DDK)
Program Officer: Sato, Sheryl M


NIH 2004 R01 DK	Igf2r Tumor Suppression in Igf2 and TGFa Transgenic Mice Pravtcheva, Dimitrina D. / Institute for Basic Research in Dev Disabil	$247,676
NIH 2003 R01 DK	Igf2r Tumor Suppression in Igf2 and TGFa Transgenic Mice Pravtcheva, Dimitrina D. / Institute for Basic Research in Dev Disabil	$244,923
NIH 2002 R01 DK	Igf2r Tumor Suppression in Igf2 and TGFa Transgenic Mice Pravtcheva, Dimitrina D. / Institute for Basic Research in Dev Disabil	$242,263
NIH 2001 R01 DK	Igf2r Tumor Suppression in Igf2 and TGFa Transgenic Mice Pravtcheva, Dimitrina D. / Institute for Basic Research in Dev Disabil	$239,692
NIH 2000 R01 DK	Growth and Tumorigenesis in IGF2 Transgenic Mice Pravtcheva, Dimitrina D. / Institute for Basic Research in Dev Disabil	$52,825
NIH 1998 R01 DK	Growth and Tumorigenesis in IGF2 Transgenic Mice Pravtcheva, Dimitrina D. / Institute for Basic Research in Dev Disabil
NIH 1996 R01 DK	Growth and Tumorigenesis in IGF2 Transgenic Mice Bulla, Gary A. / Saint Louis University
NIH 1995 R01 DK	Growth and Tumorigenesis in IGF2 Transgenic Mice Pravtcheva, Dimitrina D. / Saint Louis University
NIH 1994 R01 DK	Growth and Tumorigenesis in IGF2 Transgenic Mice Pravtcheva, Dimitrina D. / Saint Louis University

Wise, Thomas L; Pravtcheva, Dimitrina D (2006) Delayed onset of Igf2-induced mammary tumors in Igf2r transgenic mice. Cancer Res 66:1327-36

Pravtcheva, Dimitrina D; Wise, Thomas L (2003) Transgene instability in mice injected with an in vitro methylated Igf2 gene. Mutat Res 529:35-50